Market Newsdesk

Cascade Launches New & Improved Platinum Plus to Tackle Today’s Toughest Meal Cleanups

Cascade partners with Comedian Kenan Thompson to Put Its Newest Formula to the Test and Let the Dishwasher Do The Work

CINCINNATI–(BUSINESS WIRE)–
Cascade^®, America’s #1 recommended dishwasher detergent brand*, is launching New & Improved Cascade Platinum Plus to address consumers’ top concerns of stuck-on food, tough grease and spotty dishes. The new product features an upgraded formula designed to remove up to 100% of food and deliver a virtually spot-free shine and dry. In a new campaign to support the launch, the brand has enlisted comedian Kenan Thompson to help put the product to the test and encourage consumers to embrace cooking at home without fear of the tedious cleanup.

This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20250310626982/en/

Kenan Thompson and Cascade have teamed up to show how simple doing the dishes and cleaning up can be now thanks to New & Improved Cascade Platinum Plus. (Photo: Cascade)

More than one-third of Americans are now cooking at home four to six times per week, with more than 25% inspired by meal ideas sourced from their social media feeds.** A recent study by Procter & Gamble looked at today’s most popular recipes and found a significant rise in the use of complex ingredients like proteins. Meat ranked at the top of the list, while cheese and eggs ranked in the top five most used ingredients. Cascade designed its new ActionPacs using a proprietary enzyme designed to work specifically on these traditionally tough-to-clean food combinations (like cheesy, baked on eggs and pan-seared meats) and included the grease-fighting power of Dawn.

“One of our top priorities is making sure that our products and innovations evolve with the consumers’ needs. Through research, we discovered that people are becoming more adventurous in the kitchen. They’re cooking with more complex ingredients, and we needed to ensure that our formula was leveling up the same way that consumers are with their cooking. New & Improved Cascade Platinum Plus can tackle even the toughest messes being made in the kitchen today, delivering a superior clean,” says Angelica Matthews, Brand Vice President, North America Dish Care, Procter & Gamble.

Cascade Partners with Comedian Kenan Thompson

To encourage consumers to fearlessly take their at-home cooking (and cleaning) up a notch, Cascade has teamed up with comedian Kenan Thompson, a longtime Cascade user, to deliver a humorous and relatable take on the dreaded aftermath of cleaning a swarm of dirty dishes and pans in a new social media video, showing how simple the process can be now thanks to New & Improved Cascade Platinum Plus.

“I love cooking at home, but the dread of the cleanup can hold me back from making the meals I want.” says Thompson. “With the New & Improved Cascade Platinum Plus I can throw in my dirtiest, greasiest dish in the dishwasher, and it comes out clean every time. As a long-time Cascade-user, I can confidently say this is their best yet. I’m a cooking machine now that I’m totally confident the dishwasher will get the job done.”

With New & Improved Cascade Platinum Plus, dishwashing is as simple as scrape, load, and you’re done—no pre-rinsing or rewashing required. The brand is so confident in the new formula that it’s offering a money back guarantee so consumers can try the product risk-free.

New & Improved Cascade Platinum Plus is available for purchase at grocery and mass retailers nationwide, in a variety of sizes starting at $4.94 MSRP (pricing at the sole discretion of the retailer).

About Cascade

In 1953, Cascade® entered the automatic dishwashing market with claims of “spotless dishes” to the four percent of households with dishwashers. The fast-moving world of household innovations was just in its beginning stages, and Cascade stayed at the forefront for the next 50 years by developing a range of automatic dishwashing products perfect for a variety of families, needs, and lifestyles. Today, with decades of experience and dishwashers in more than 60-percent of households, Cascade continues to grow, striving for immaculate dishes every time with its brilliant automatic dishwashing powders, gels, pacs, and additives.

About Procter & Gamble

P&G serves consumers around the world with one of the strongest portfolios of trusted, quality, leadership brands, including Always®, Ambi Pur®, Ariel®, Bounty®, Charmin®, Crest®, Dawn®, Downy®, Fairy®, Febreze®, Gain®, Gillette®, Head & Shoulders®, Lenor®, Olay®, Oral-B®, Pampers®, Pantene®, SK-II®, Tide®, Vicks®, and Whisper®. The P&G community includes operations in approximately 70 countries worldwide. Please visit https://www.pg.com for the latest news and information about P&G and its brands. For other P&G news, visit us at https://www.pg.com/news.

View source version on businesswire.com: https://www.businesswire.com/news/home/20250310626982/en/

For media inquiries, please contact: Casey Miller, [email protected]

KEYWORDS: United States North America Ohio

INDUSTRY KEYWORDS: Other Consumer Home Goods Women Retail Men Convenience Store Family Consumer Social Media Entertainment Other Communications Marketing Other Retail Advertising Communications Supermarket General Entertainment Celebrity

MEDIA:

Photo

Kenan Thompson and Cascade have teamed up to show how simple doing the dishes and cleaning up can be now thanks to New & Improved Cascade Platinum Plus. (Photo: Cascade)

Photo

New & Improved Cascade Platinum Plus removes up to 100% of food and delivers a virtually spot free shine and dry—it’s Kenan Thompson approved! (Photo: Cascade)

Photo

The post-meal dish dread is real, but with New & Improved Cascade Platinum Plus, you can trust the dishwasher to get the job done. (Photo: Cascade)

Photo

With New & Improved Cascade Platinum Plus, dishwashing is as simple as scrape, load, and you’re done—no pre-rinsing or rewashing required. It cleans the toughest messes hassle-free. (Graphic: Cascade)

Photo

Cascade, America’s #1 recommended dishwasher detergent brand*, launched New & Improved Cascade Platinum Plus to address consumers’ top concerns of stuck-on food, tough grease and spotty dishes. (Photo: Cascade)

Logo

Palladyne AI Selected for Participation at USSOCOM TE25-2: Collaborative Autonomy Integration Event

SALT LAKE CITY–(BUSINESS WIRE)–Palladyne AI Corp. (NASDAQ: PDYN and PDYNW) (“Palladyne AI”), a developer of artificial intelligence software for robotic platforms in the defense and commercial sectors, today announced that the Company has been selected for participation at TE25-2: Collaborative Autonomy Integration, hosted by the U.S. Special Operations Command (USSOCOM) Technical Experimentation Team and taking place from April 14-17, 2025, at Avon Park Air Force Range in Avon Park, FL. Palladyne AI will be showcasing its Palladyne^™ Pilot AI Software Platform at the event.

The USSOCOM Technical Experimentation program brings together Special Operations Forces (SOF) operational users, acquisition and technology program managers, and technology developers (industry, government research and development labs, and academia) in a collaborative environment to evaluate new technologies in the developmental stages for SOF applications. The goal of this event is to highlight technologies allowing SOF operators to evaluate a digital network of autonomous systems leveraging AI to collaborate in real time. These systems are designed to perform tactical tasks in the joint and combined operating environment with actions conducted across the spectrum of integrated deterrence and capabilities enabling joint and combined operations to deliver a superior decision advantage.

Palladyne AI will demonstrate its Palladyne Pilot AI Software Platform for UAVs throughout the TE25-2: Collaborative Autonomy Integration event. The Pilot AI software transforms unmanned tactical systems into highly efficient autonomous force multipliers capable of persistent target tracking, dynamic collaboration, and enhanced situational awareness. With advanced perception, learning, and autonomous capabilities designed to reduce operational burden while dramatically improving mission effectiveness for military and defense operations, Palladyne Pilot stands ready to support and deliver mission effectiveness and success.

For more information about Palladyne Pilot, please visit https://www.palladyneai.com/pilot.

About Palladyne AI Corp.

Palladyne AI Corp. (NASDAQ: PDYN) has developed advanced artificial intelligence (AI) and machine learning (ML) foundational technology and related software products poised to revolutionize the capabilities of robots, enabling them to observe, learn, reason, and act in a manner akin to human intelligence. Our AI and ML software foundational technology empowers robots to perceive variations or changes in the real-world environment, enabling them to autonomously maneuver and manipulate objects accurately in response.

Palladyne AI software products operate on the edge and dramatically reduce the significant effort required to program and deploy robots enabling industrial robots and collaborative robots (cobots) to quickly achieve autonomous capabilities even in dynamic and or complex environments. Designed to achieve precise results with minimal training time, limited data sets, and lower power requirements, compared to current state-of-the-art solutions, Palladyne AI believes its software has wide application, including in industries such as automotive, aviation, construction, defense, general manufacturing, infrastructure inspection, logistics and warehousing. Its applicability extends beyond traditional robotics to include Unmanned Aerial Vehicles (UAVs), Unmanned Ground Vehicles (UGVs), and Remotely Operated Vehicles (ROVs). Palladyne AI’s approach is expected to elevate the return on investment associated with a diverse range of machines that are fixed, fly, float, or roll.

By enabling autonomy, reducing programming complexity, and enhancing efficiency, Palladyne AI is paving the way for a future where machines can excel in tasks that were once considered beyond their reach.

For more information, please visit www.palladyneai.com and connect with us on LinkedIn at www.linkedin.com/company/palladyneaicorp.

Forward-Looking Statements

This press release contains forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995, including statements regarding the capabilities or future capabilities of the Company’s AI/ML foundational technology and related software products, the benefits of the software and the industries that could benefit from it, and the applicability of the software to different kinds of machines (such as UAVs, UGVs and ROVs). Forward-looking statements are inherently subject to risks, uncertainties, and assumptions. Generally, statements that are not historical facts, including statements concerning possible or assumed future actions, business strategies, events, or results of operations, are forward-looking statements. These statements may be preceded by, followed by, or include the words “believes,” “estimates,” “expects,” “projects,” “forecasts,” “may,” “will,” “should,” “seeks,” “plans,” “scheduled,” “anticipates,” “intends” or “continue” or similar expressions. Such forward-looking statements involve risks and uncertainties that may cause actual events, results, or performance to differ materially from those indicated by such statements. These forward-looking statements are based on Palladyne AI’s management’s current expectations and beliefs, as well as a number of assumptions concerning future events. However, there can be no assurance that the events, results, or trends identified in these forward-looking statements will occur or be achieved. Forward-looking statements speak only as of the date they are made, and Palladyne AI is not under any obligation and expressly disclaims any obligation, to update, alter or otherwise revise any forward-looking statement, whether as a result of new information, future events, or otherwise, except as required by law.

Readers should carefully review the statements set forth in the reports which Palladyne AI has filed or will file from time to time with the Securities and Exchange Commission (the “SEC”), in particular the risks and uncertainties set forth in the sections of those reports entitled “Risk Factors” and “Cautionary Note Regarding Forward-Looking Statements,” for a description of risks facing Palladyne AI and that could cause actual events, results or performance to differ from those indicated in the forward-looking statements contained herein. The documents filed by Palladyne AI with the SEC may be obtained free of charge at the SEC’s website at www.sec.gov.

View source version on businesswire.com: https://www.businesswire.com/news/home/20250310487062/en/

Palladyne AI Corp PR and Investor Contacts:

Press Contact:

[email protected]

Investor Contact:

[email protected]

KEYWORDS: United States North America Utah Florida

INDUSTRY KEYWORDS: Software Networks Other Defense Internet Contracts Hardware Robotics Data Management Apps/Applications Technology Defense Artificial Intelligence Military

MEDIA:

Logo

GoodRx Report Reveals Striking Gender Divide in Prescription Medication Spending

Women Spent $8.8 Billion More than Men in 2024, with Women Ages 18-44 Facing the Steepest Out-of-Pocket Cost Disparity

SANTA MONICA, Calif.–(BUSINESS WIRE)–GoodRx (Nasdaq: GDRX), the leading platform for medication savings in the U.S., today released a new report, The Prescription Drug Gender Divide, detailing how women shoulder a significantly greater out-of-pocket cost burden than men. The data shows that in 2024, women spent $8.8 billion – or 30% – more than men on out-of-pocket prescription costs. Combined with the common responsibilities of managing a career, family planning, and caregiving, women are left frustrated with the financial pressure required to maintain their health.

Though the “pink tax” is often thought about as higher prices on consumer goods, the research suggests that it also manifests itself in the hidden costs of healthcare. Higher healthcare utilization, higher rates of chronic conditions, and spending on female-specific conditions like women’s fertility and menopause contribute to this imbalance. Women are filling more prescriptions than men, but forgoing treatment isn’t more cost effective in the long run, either. If left untreated, many of the conditions women are proactively managing can be debilitating, interrupting their lives and work, and necessitating more serious and expensive medical interventions down the line.

Highlights from the new report include:

• Women spent almost $40 billion in total out-of-pocket prescription costs in 2024: Women spent 30% more out-of-pocket than men last year, a trend that has remained consistent over recent years.
• Out-of-pocket spending on female-specific conditions exceeded $1.5 billion in 2024: Menopause treatments, for example, cost an average of $16.95 per prescription. Conditions that demand specialized treatments, like endometriosis and morning sickness, require an even more substantial spend ($29.38 and $37.87 per prescription, respectively).
• The gender gap is largest for women ages 18 to 44: Women ages 18 to 44 spend up to 64% more out-of-pocket on medications than men of the same age group. As they age, the gap gets smaller. Women ages 45 to 64 spent 35.3% more than men in 2024, and women over 65 spent 16.5% more.
• Women significantly outspend men on mental health treatments. Women spend 113% more out-of-pocket on depression medications and 103% more on anxiety treatments than men. These disparities are likely driven by both higher prescription fill rates and systemic factors, such as differences in how mental health conditions are diagnosed and treated between genders.

“Though we typically think of the ‘pink tax’ as an upcharge on goods and services, these latest findings illustrate how the spending gap between men and women transcends grocery store shelves, with women paying a premium just to maintain their health,” says Tori Marsh, MPH, Director of Research at GoodRx. “This gender inequality leaves women with a greater financial burden, potentially requiring women to choose between their own health and other recurring expenses. This can lead to more serious health issues and create extra strain–not just on individuals–but on the healthcare system as a whole.”

To address the gender gap, GoodRx is helping women save time and money when filling their medications at more than 70,000 pharmacies nationwide. This includes offering savings on medications for female-specific conditions, like birth control, menopause treatments, and fertility medications, as well as other conditions that disproportionately affect women. These savings include:

• Fertility Treatments: Discounts of up to 43% on fertility treatments based on the best available GoodRx price, including savings on both brand-name and generic medications used in IVF
• Menopause Hormone Therapies: Low cash prices for menopause hormone therapies by Pfizer in the range of $99-$249
• Birth Control: A seamless ecommerce option for purchasing Opill, the first over-the-counter daily birth control pill, and significant discounts on prescription birth control
• Mental Health and Autoimmune Medications: Low cash prices for critical medications like Pristiq, Cytomel and Synthroid
• Common Heart Health Medications: 30 of the most common heart health medications are available on GoodRx for under $30

“Affordable healthcare doesn’t just support better health and quality of life for women, but has a positive ripple effect on our families, communities and healthcare system,” said Dorothy Gemmell, Chief Commercial Officer at GoodRx. “At GoodRx, we are working closely with healthcare’s key stakeholders–from pharmaceutical companies to retail pharmacies–to help women at all stages of life access lower prices on essential medications.”

This research was debuted at SXSW 2025 during a GoodRx-moderated session titled “The Hidden Pink Tax Fueling High Healthcare Costs for Women,” which included an all-women panel, with participants representing pharmacies, pharmaceutical manufacturers, and telehealth platforms.

The full Prescription Drug Gender Divide report is available from GoodRx Research, here.

About GoodRx

GoodRx is the leading platform for medication savings in the U.S., used by nearly 30 million consumers and over one million healthcare professionals annually. Uniquely situated at the center of the healthcare ecosystem, GoodRx connects consumers, healthcare professionals, payers, PBMs, pharma manufacturers, and retail pharmacies to make saving on medications easier. By reducing friction and inefficiencies, GoodRx helps consumers save time and money when filling prescriptions so they can get the care they deserve. Since 2011, GoodRx has helped Americans save over $85 billion on the cost of their medications.

​GoodRx periodically posts information that may be important to investors on its investor relations website at https://investors.goodrx.com. We intend to use our website as a means of disclosing material nonpublic information and for complying with our disclosure obligations under Regulation FD. Accordingly, investors and potential investors are encouraged to consult GoodRx’s website regularly for important information, in addition to following GoodRx’s press releases, filings with the Securities and Exchange Commission (the “SEC”) and public conference calls and webcasts. The information contained on, or that may be accessed through, GoodRx’s website is not incorporated by reference into, and is not a part of, this press release.

Forward-Looking Statements

This press release contains forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. All statements contained in this press release that do not relate to matters of historical fact should be considered forward-looking statements, including, without limitation, statements regarding anticipated consumer savings and accessibility; and the objectives and potential benefits and value of the GoodRx research and savings. These statements are neither promises nor guarantees, but involve known and unknown risks, uncertainties and other important factors that may cause our actual results, performance or achievements to be materially different from any future results, performance or achievements expressed or implied by the forward-looking statements, including, but not limited to, risks relating to our ability to achieve broad market education and change consumer purchasing habits; changes in medication pricing and pricing structures; our reliance on a limited number of industry participants; and the important factors discussed under the caption “Risk Factors” in our Annual Report on Form 10-K for the year ended December 31, 2024, and our other filings with the SEC. Any such forward-looking statements are based on current expectations, projections and estimates as of the date of this press release. While we may elect to update such forward-looking statements at some point in the future, we disclaim any obligation to do so, even if subsequent events cause our views to change.

View source version on businesswire.com: https://www.businesswire.com/news/home/20250310126491/en/

Press Contact

GoodRx

[email protected]

KEYWORDS: United States North America California

INDUSTRY KEYWORDS: Software Men Internet Pharmaceutical Data Management Consumer Technology Hospitals Health Technology Health Insurance Women Health

MEDIA:

Logo

flyExclusive Launches Jet Club with Unmatched Flexibility and Transparency

Streamlined Jet Club offers guaranteed access to Challenger fleet

KINSTON, N.C.–(BUSINESS WIRE)–
flyExclusive, Inc. (NYSEAMERICAN: FLYX) (“flyExclusive” or the “Company”), a publicly-traded provider of premium private jet charter experiences, today announced the launch of its latest Jet Club, a simplified, high-value private jet membership designed for those who demand 365-day access, transparency, and elite service.

The Jet Club offers a streamlined membership featuring locked-in rates, integrated funding bonuses, and guaranteed access to flyExclusive’s extensive company fleet, including the Premium Super-Mid category featuring the Challenger 300 and 350.

“Our goal was to create the simplest, most transparent jet membership in private aviation, and we believe our latest version of the Jet Club accomplishes that,” said Mike Guina, flyExclusive’s Chief Commercial Officer. “We’ve refined our Jet Club to provide members with transparent pricing and unmatched flexibility featuring our unique pricing model that delivers unparalleled efficiency. We’re proud to set the new industry standard in private jet club membership and further our commitment to providing an exceptional private aviation experience for customers.”

With no blackout dates, no fuel surcharges, and exclusive “Deal Day” perks, flyExclusive’s Jet Club is built for seamless, stress-free travel—whether flying for business or leisure.

Jet Club Highlights:

✈ Integrated Funding Bonuses – More value every time you fly

✈ Guaranteed Access to Premium Super-Mid Aircraft – Including the Challenger 300/350

✈ Rates Locked for 24 Months – No surprises, no fuel surcharges or escalations

✈ Special “Deal Day” Opportunities – Exclusive member-only discounts

✈ Capped Number of High-Demand Days – Predictable pricing, even during peak seasons

Ready to take off? VisitflyExclusive.comto learn more.

About flyExclusive

flyExclusive is a vertically integrated, FAA-certificated air carrier providing private jet experiences by offering customers a choice of on-demand charter, Jet Club, and fractional ownership services to destinations across the globe. flyExclusive has one of the world’s largest fleets of Cessna Citation aircraft, and it operates a combined total of approximately 100 jets, ranging from light to large cabin sizes. The company manages all aspects of the customer experience, ensuring that every flight is on a modern, comfortable, and safe aircraft. flyExclusive’s in-house repair station, aircraft paint, cabin interior renovation, and avionics installation capabilities, are all provided from its campus headquarters in Kinston, North Carolina. To learn more, visit www.flyexclusive.com.

Cautionary Statement Regarding Forward-Looking Statements

This press release contains certain forward-looking statements within the meaning of the federal securities laws. These forward-looking statements generally are identified by the words “believe,” “project,” “expect,” “anticipate,” “estimate,” “intend,” “strategy,” “future,” “opportunity,” “plan,” “may,” “should,” “will,” “would,” “will be,” “will continue,” “will likely result,” and similar expressions. Forward-looking statements are predictions, projections, and other statements about future events that are based on current expectations and assumptions and, as a result, are subject to risks and uncertainties. Many factors could cause actual future events to differ materially from the forward-looking statements in this document, including but not limited to: risks related to reliance on and the need to hire, integrate and retain key personnel; management of growth; the ability of the Company to file timely file its required annual and quarterly reports with the SEC; the ability of the Company to regain compliance with NYSE American continued listing standards and maintain the listing of the Company’s securities on a national securities exchange; the ability of the Company to comply with covenants under and repay its debt; the potential dilution of stock ownership by our capital raising efforts; the outcome of any legal proceedings; volatility of the price of the Company’s securities due to a variety of factors, including publication of articles about the Company by third parties, changes in the competitive and highly regulated industries in which flyExclusive operates, variations in operating performance across competitors, changes in laws and regulations affecting flyExclusive’s business; the ability to implement business plans, forecasts, and other expectations, and identify and realize additional opportunities; and the risk of downturns and a changing regulatory landscape in the highly competitive aviation industry. The foregoing list of factors is not exhaustive. You should carefully consider the foregoing factors and the other risks and uncertainties described in the “Risk Factors” section of flyExclusive’s registration statement on Form S-1 and other documents filed by the Company from time to time with the SEC. These filings identify and address other important risks and uncertainties that could cause actual events and results to differ materially from those contained in the forward-looking statements. Forward-looking statements speak only as of the date they are made. Readers are cautioned not to put undue reliance on forward-looking statements, and the Company assumes no obligation and does not intend to update or revise these forward-looking statements, whether as a result of new information, future events, or otherwise. The Company does not give any assurance that it will achieve its expectations.

View source version on businesswire.com: https://www.businesswire.com/news/home/20250307665378/en/

Media Contact: Jillian Wilson, Marketing Specialist

[email protected]

Investor Relations Contact: Sloan Bohlen, Solebury Strategic Communications

[email protected]

KEYWORDS: United States North America North Carolina

INDUSTRY KEYWORDS: Entertainment Family Luxury Vacation Consumer Other Travel Transportation Travel General Entertainment Retail Air Transport

MEDIA:

Logo